Australia's Bionomics Keeps Major-Investor Financial Support
This article was originally published in PharmAsia News
Executive Summary
Australian start-up biotech Bionomics escaped a major reduction in its financial support when a venture-capital firm decided not to sell its one-quarter share
Australian start-up biotech Bionomics escaped a major reduction in its financial support when a venture-capital firm decided not to sell its one-quarter share. Start-Up Ventures Australia, owner of 27.76% of Bionomics, had put its shares on sale with a March 31 deadline, with a 20% bid leading to a full takeover of the biotech. The investor changed its mind, citing recent reports of research advances by Bionomics. (Click here for more) "Bionomics Shareholder To Retain Stake" - Adelaide Now (Australia) (4/12/11) |